IL6 and aneurysm: Shimada and coworkers showed that use of the peroxisome proliferator-activated receptor-γ (PPARγ) pioglitazone in a mouse model protects against aneurysm rupture, and that this was associated with a reduction of IL-6 mRNA levels [19].